WHO embarked on 13th Global Programme of Work (GPW13) for strategic direction in Sustainable Development Agenda 2030 (SDG) for health which is vital for the future of our world. Access to effective, safe, quality-assured and affordable medical products (medicines, vaccines, diagnostics, devices) is key to making progress towards Universal Health Coverage (UHC) and the SDGs. The 72nd session of the World Health Assembly adopted a resolution on improving the transparency of markets for medicines, vaccines and other health products in an effort to expand access.

Access to essential medicines has been a priority in the Regional Flagship on UHC. The Health Ministers of the Member States of the WHO South-East Asia Region participating in the Seventy-first session of the WHO Regional Committee for South-East Asia in New Delhi, India adopted the Delhi Declaration on ‘Improving access to essential medical products in the South-East Asia Region and beyond’.

India’s contribution towards access to medical products worldwide is well recognized, India being a major hub for manufacturing of medical products including generics. India is engaged in scientific progress and Research & Development for development of affordable products with supportive technology platforms, network of clinical sites and testing facilities, and health technology innovation for meeting critical global health needs. The 2019 World Conference is an important forum for all bringing innovative thinking on contemporary public health issues.